The decision to use branded Qsymia or the separate components is always made collaboratively with the patient and depends on insurance, cost considerations, and dose precision
Similarly, the SURMOUNT-4 trial showed substantial weight regain following tirzepatide discontinuation
Research suggests people with a stronger natural GLP-1 response after eating may consume 20% to 30% fewer calories at their next meal
Common Side Effects Gastrointestinal: Nausea, vomiting, abdominal cramps, and diarrhea the most common adverse effects, occurring primarily at doses exceeding 3 g/day [1][5][7]
Understanding Mounjaro for Type 2 Diabetes Mounjaro, containing the active ingredient tirzepatide, is an FDA-approved prescription medication specifically designed for adults managing type 2 diabetes